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Abstract
 
The immune response of naive CD4 T cells to influenza virus is initiated in the draining lymph
nodes and spleen, and only after effectors are generated do antigen-specific cells migrate to the
lung which is the site of infection. The effector cells generated in secondary organs appear as
multiple subsets which are a heterogeneous continuum of cells in terms of number of cell divi-
sions, phenotype and function. The effector cells that migrate to the lung constitute the more
differentiated of the total responding population, characterized by many cell divisions, loss of
CD62L, down-regulation of CCR7, stable expression of CD44 and CD49d, and transient ex-
pression of CCR5 and CD25. These cells also secrete high levels of interferon 
 
 
 
 and reduced
levels of interleukin 2 relative to those in the secondary lymphoid organs. The response de-
clines rapidly in parallel with viral clearance, but a spectrum of resting cell subsets reflecting the
pattern at the peak of response is retained, suggesting that heterogeneous effector populations
may give rise to corresponding memory populations. These results reveal a complex re-
sponse, not an all-or-none one, which results in multiple effector phenotypes and implies
that effector cells and the memory cells derived from them can display a broad spectrum of
functional potentials.
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Introduction
 
Adoptive transfer models, often using T cell receptor trans-
genic (Tg)
 
*
 
 donor cells, have enabled the study of primary
immune responses in situ which have begun to yield new
insights into the mechanisms involved in that response.
Studies from Jenkins’ laboratory have visualized the CD4 T
cell response in the lymph nodes and spleen, highlighting
the initial interaction of naive CD4 T cells, with dendritic
cells presenting antigen, followed by the movement of the
donor cells to other sites (1). A number of transfer studies
with CD8 T cells have suggested that initial effective en-
counter with antigen in vivo, is sufficient to support activa-
tion and multiple rounds of cell division (2–4). The latter
study suggested that CD8 T cells may respond in an all-or-
none fashion. However, other studies have been more
compatible with a heterogeneous response in vivo (5). A
number of recent studies have indicated that during a pri-
mary immune response, effector cells become widely dis-
tributed to multiple sites (6–9), where they may have differ-
ent functional potentials (6, 10–12). Lanzavecchia and
colleagues have proposed a division of memory T cells into
central memory cells residing in secondary lymphoid tissues
and identified by presence of CCR7 and effector memory
residing in tertiary tissue sites and identified by the absence
of CCR7 (10, 13). The pathways giving rise to these differ-
ent populations and the factors influencing such possible
pathways are largely undefined.
We have analyzed the primary CD4 T cell response to
influenza virus to determine whether the effector cells gen-
erated are heterogeneous and whether different subsets of
effectors have different functional and phenotypic attributes
and abilities to be recruited to a tertiary inflammatory site.
We have used Thy1 disparate donor TCR Tg cells spe-
cific for viral hemagglutinin, adoptively transferred into
normal BALB/c mice. Naive donor cells were labeled
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Abbreviations used in this paper:
 
 APC, allophycocyanin; BAL, bronchial
alveolar lavage; BrdU, 5
 
 
 
-bromo-2
 
 
 
-deoxyuridine; CFSE, carboxyfluo-
rescein diacetate succinimidyl ester; ICCS, intracellular cytokine staining;
MDCK, Madin Darby canine kidney; MLN, mediastinal LN; pLN,
pooled nondraining peripheral LN; Tg, transgenic. 
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with a vital dye to detect their subsequent division in re-
sponse to influenza virus. The transferred population was
identified by using both the Thy1 difference and Ab to
the TCR. The model described here has several distinct
features. Influenza virus is administered intranasally where
it first infects airway epithelial cells. The virus replicates
only in these cells (14, 15), so virus and inflammation are
colocalized in the lung. Both CD4 and CD8 T cells re-
spond vigorously to influenza infection and both can par-
ticipate in clearing virus (16–18). Because the sublethal
dose of the virus used is cleared effectively (18), antigen is
present only for a limited time, allowing an acute primary
response, followed by a resolution of that response and
development of memory.
The CD4 T cell response was visualized by the changes
in a variety of key phenotypic markers. The response was
broadly heterogeneous, beginning in the draining LNs
and spleen and then spreading to other secondary lym-
phoid sites. By 6 d, a cohort of this effector population,
defined by many rounds of cell division and the most ex-
tensive phenotypic conversion, was recruited into the
lungs and bronchial alveolar lavage (BAL). This pheno-
typic and functional heterogeneity was maintained to the
end of the response after virus had been cleared and effec-
tors had acquired a resting phenotype. These studies re-
vealed that even a homogeneous population of naive cells
responded in a heterogeneous fashion in vivo, that there
was a broad spectrum of possible responses defined by
multiple criteria and that only a cohort of effectors were
recruited into the site of infection and inflammation,
where they participated in the antiviral response. More-
over these studies suggest that when response subsides, a
small population of resting cells, representing a spectrum
of heterogeneous subsets which reflect the effector pat-
tern, persist and are likely to be the origin of multiple
memory subsets.
 
Materials and Methods
 
Mice.
 
BALB/c mice were purchased from The Jackson Labo-
ratory at 6–8 wk of age. HNT TCR transgenic mice were gener-
ated and characterized as described previously (19). CD4 T cells
from these mice express V
 
 
 
8.3 TCR transgene derived from
clone T2.5–5 specific for the hemagglutinin peptide 126–138
(HNTNGVTAACSHE) presented on I-A
 
d
 
 (20). HNT mice
were bred and obtain from the Trudeau Institute’s Animal Breed-
ing facility. They were backcrossed for at least 12 generations to
BALB/c mice and to BALB/c Thy1.1 mice, originally obtained
from Dr. Jonathan Sprent (The Scripps Research Institute, La
Jolla, CA).
 
Purification of Naive Influenza-specific CD4 T Cells.
 
Naive
CD4 T cells were purified from HNT BALB/c.Thy1.1 mice.
Cell suspensions from spleen and LN were passed over nylon
wool column followed by separation on a percoll gradient with
layers 80–62–53–40%. T cells recovered from the 80–62% inter-
face were further enriched using a CD4 subset column (R&D
Systems) as described by manufacturer. The naive CD4 T cell
population obtained was 
 
 
 
97% HNT TCR
 
positive
 
 and expressed a
characteristic naive phenotype, including small size as detected by
FACS
 
®
 
 analysis, high levels of L-selectin and CD45RB and low
expression of CD25.
 
Adoptive Cell Transfer and Virus Infection.
 
Naive CD4 T cells
were labeled with carboxyfluorescein diacetate succinimidyl ester
(CFSE; Molecular Probes, Inc.) as described previously (21).
Each BALB/c recipient received 5 
 
 
 
 10
 
6
 
 CFSE-labeled cells in
0.2 ml of PBS by intravenous injection in the tail. Influenza A vi-
rus (A/PR/8/34) was grown in the allantoic fluid of 10-d old
embryonated chicken eggs, from an aliquot originally obtained
from Dr. David Morgan (The Scripps Research Institute, La
Jolla, CA). Adoptively transferred mice were inoculated intrana-
sally during light isoflurane anesthesia with 0.5
 
 
 
 LD
 
50
 
 of virus,
corresponding to a 1:30,000 dilution of a stock containing 3 
 
 
 
10
 
6
 
 PFU/ml, in 100 
 
 
 
l of PBS.
 
Tissue Preparation.
 
At different time points after virus infec-
tion, 3 to 5 mice per group were exsanguinated, under deep iso-
flurane anesthesia, by perforation of the abdominal aorta. Cells
from the BAL were collected by lavage of the airways, three
times with 1 ml of cold RPMI. Lungs were then perfused by in-
jecting 3 ml of PBS in the left ventricle of the heart. Lungs,
spleen, draining LN (mediastinal LN [MLN]), and a pool of non-
draining peripheral LN (pLN) including mesenteric, axillary, bra-
chial, inguinal, and periaortic, were taken from each mouse. Sin-
gle cell suspensions were prepared by passing the organs through
a nylon cell strainer. Leukocytes were separated from lung sus-
pensions by resuspending the cells in 80% percoll, overlaid with
40% percoll. After centrifugation at 1,700 rpm for 20 min, cells at
the 80–40% interface were collected, washed, counted, and ana-
lyzed further by flow cytometry.
 
Viral Plaque Assay.
 
Viral titer in infected lungs were deter-
mined using a modified Madin Darby canine kidney (MDCK)
cell plaque assay (16). At the indicated times, lungs were snap fro-
zen in liquid nitrogen and stored at 
 
 
 
70
 
 
 
C until ready for use.
MDCK monolayers were grown in DMEM supplemented with
10% FCS, 0.01 mM MEM, nonessential amino acids, 1 mM so-
dium pyruvate (GIBCO BRL), and PSG (200 IU/ml of penicil-
lin, 200 
 
 
 
g/ml streptomycin, and 4 mM glutamine). 10-fold di-
lutions of the lung homogenates were prepared in DMEM
supplemented with 0.2% BSA, 2 mg/ml NaHCO
 
3
 
, 2 mM Hepes
and PSG. 100 
 
 
 
l of each dilution was added to confluent mono-
layers of MDCK cells in 12 well plates in duplicates for 1 h 37
 
 
 
C,
7% CO
 
2
 
. Each well received 1 ml of an agar overlay medium
containing DMEM with 0.2% BSA, 2 mg/ml NaHCO
 
3
 
, 2 mM
Hepes, PSG, 0.5% agar (Sigma Aldrich), 0.01% DEAE Dextran,
and 0.5 
 
 
 
g/ml trypsin. After 3 d of incubation at 37
 
 
 
C, cells were
fixed with 0.5ml Carnoy’s fixative (3:1) methanol/glacial acetic
acid for 20 min. The agar overlay was then removed and fixed
monolayers stained by adding 1:10 dilution of 2% crystal violet
prepared in 20% ethanol. The results are presented as PFU/ml 
 
 
 
(mean number of plaques /0.1) 
 
 
 
 (1/dilution factor).
 
Flow Cytometry.
 
The percentages of donor HNT TCR Tg
CD4 Thy1.1
 
 
 
 cells in each organ was determined by FACS
 
®
 
analysis. Cell suspensions were first incubated 10 
 
 
 
l of anti-
CD16/CD32 (BD Biosciences) to block Fc receptors. The cells
were then stained with anti-Thy1.1-biotin followed by streptavi-
din-allophycocyanin (APC), anti-V
 
 
 
8.3-PE, and anti-CD4-Cyc.
The following mAb were used for phenotype staining: anti-
CD44-PE, anti-CD62L-PE, anti-CD49d-PE, anti-CCR5-PE,
and a mixture of anti-IgG1-PE, anti-IgG2a-PE, anti-IgG2b-PE,
and anti-IgG2c-PE were used as isotype controls (BD Bio-
sciences). CCR7 expression was detected using the recombinant
ligand, ELC-Ig, obtained from von Andrian’s laboratory (22). To
stain for CCR7 cell suspensions were incubated with ELC-Ig (1 
959
 
Román et al.
 
 
 
g/ml) followed by goat anti–human Fc biotin and streptavidin-
APC (22). In this particular staining, donor cells were identified
using anti-Thy1.1-PE and CD4 PerCP. Flow cytometry was per-
formed using FACSCalibur™ and the data were analyzed with
CELLQuest™ software (Becton Dickinson). The total number
of donor cells per organ were calculated by assessing percentage
of donor Thy1.1
 
 
 
 cells by FACS
 
®
 
, multiplied by total number of
cells recovered from each organ.
 
5
 
 
 
-Bromo-2
 
 
 
-Deoxyuridine Staining.
 
T cell proliferation in
vivo was measured by 5
 
 
 
-bromo-2
 
 
 
-deoxyuridine (BrdU) incor-
poration. BALB/c recipient mice were feed orally with BrdU
(Sigma-Aldrich) dissolved in water (1 mg/ml) every day. Oral
delivery of BrdU by gavage was more effective than BrdU in the
drinking water since the infected mice often would not drink a
dependable volume of water. At 2 d intervals, organs were col-
lected and donor cells were enumerated by staining with anti-
CD4 cychrome, anti-Thy1.1 biotin, and streptavidin-APC.
BrdU incorporation was detected as described previously (23) by
staining with anti-BrdU-PE mAb and isotype control anti-IgG1-
PE mAb antibody (BD Biosciences).
 
Intracellular Cytokine Staining.
 
Staining for intracellular cyto-
kines was performed using a modification of standard techniques
(24). Briefly, cell suspensions from different organs were resus-
pended at 10
 
 
 
7
 
 cells/ml in tissue culture media and restimulated
with or without PMA (50 ng/ml) and Ionomycin (1 
 
 
 
g/ml) for
4 h. Brefeldin A (Epicentre Technologies) was added (10 
 
 
 
g/ml)
to the cultures for the last 2 h. After 4 h, cells were collected,
blocked with monoclonal antibodies to FcRIII/II receptor, and
surface stained with anti-CD4 and anti-Thy1.1 biotin followed
by streptavidin-APC (BD Biosciences) in PBS containing 1%
BSA. After fixing (4% paraformaldehyde) and permeabilization
(0.1% saponin, 1% fetal bovine serum in PBS), cells were stained
with anti-IFN-
 
 
 
-PE, anti-IL-2-PE, and the respective isotype
controls anti-IgG1-PE and anti-IgG2a-PE (BD Biosciences) in-
cubated for 30 min at room temperature. Flow cytometry was
performed as above.
 
Results
 
Kinetics of Expansion and Recruitment of Responding CD4 T
Cells.
 
Naive influenza-specific CD4 T cells were labeled
with the CFSE which segregates equally between daughter
cells, resulting in half the fluorescent intensity per cell with
each cell division (21). 5 
 
 
 
 10
 
6
 
 CFSE-labeled cells were
transferred by intravenous injection into syngeneic BALB/c
mice. Recipient mice were infected with influenza virus
A/PR8/34 by intranasal inoculation within a day (25). The
kinetics of recovery and division of donor T cells was
quantified by flow cytometry.
In control, uninfected mice examined at day 1, naive do-
nor cells were found in pLN (axillary, brachial, inguinal,
and MLNs, 3–5 
 
 
 
 10
 
5
 
) and spleen (1–2 
 
 
 
 10
 
5
 
) with few
donor cells in other sites (unpublished data, but see refer-
ence 26). Fig. 1 A shows absolute number of T cells ex-
pressing CD4 and the Thy1.1 marker that were recovered
from each tissue, at days 2, 4, 6, and 8 after infection. At
4 d, the most dramatic expansion of donor CD4 T cells had
occurred in the draining MLN and spleen, where there
were 16 and fourfold expansions, respectively, compared
with numbers of cells present in uninfected control mice at
day 1. No donor cells were detected in lung tissues or BAL
on days 2 and 4 (Fig. 1 A) or in uninfected mice (unpub-
lished data). By day 6, specific donor cell numbers peaked
in all organs with an expansion of 24-fold in spleen and 45-
fold in MLN, coupled with an abrupt appearance of donor
cells in the lung and BAL. The largest number of donor
cells was found in the spleen (
 
 
 
4 
 
 
 
 10
 
6
 
) and the next
highest in the lung and the BAL (5 
 
 
 
 10
 
5
 
; Fig. 1 A). How-
ever the percentage of donor CD4 T cells compared with
total lymphocytes, was greater in the lung (10%) and BAL
Figure 1. Kinetics of expansion
and recruitment of in vivo generated
effectors. 5   106 naive CFSE-
labeled, CD4 T cells from
HNT.Thy1.1 mice, were transferred
into normal BALB/c hosts. Recipi-
ent mice were infected intranasally
with 0.5 LD50 of A/PR8/34 (PR8,
H1N1) influenza A virus 1 d later.
At the indicated time points after in-
fection, mice were killed and spleen,
a pool of nondraining LN (pLN),
MLN, lungs, and BAL were har-
vested. The total number of cells and
percentage of CD4 Thy1.1  (donor
cells) was calculated. (A) Absolute
cell numbers of donor cells in the
organs indicated over time after in-
fluenza infection calculated using the
percentages in B. Each bar represents
three individual mice per group and
is representative of three indepen-
dent experiments. (B) The percent-
ages of donor cells obtained from
each organ. (C) The virus titer in the
lungs of BALB/c mice from day 2 to
8. Data represent mean titers from
lungs of three individual mice ana-
lyzed per time point. 
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(15%) than the spleen (2%; Fig. 1 B). Absolute donor cell
numbers in all organs tested had declined abruptly by day 8.
An analysis of donor cells after day 8 in other sites (bone
marrow, peritoneum, and fat pads) supported the concept
that total numbers per animal decreased rapidly after day 6
(unpublished data). Naive donor cells recovered from lym-
phoid organs of an uninfected control group remained
CFSE high. At day 6 naive donor cells transferred to mice
that remained uninfected were recovered mostly in spleen
(2–5 
 
 
 
 10
 
5
 
) and pLNs (1–2 
 
 
 
 10
 
4
 
).
To analyze whether the rise and fall of effector T cells
was correlated to viral titer we measured the levels of influ-
enza virus in the lung at different times after infection. The
number of influenza PFU increased rapidly after inocula-
tion reached a plateau by day 2 (
 
 
 
10
 
9
 
 PFU) and remained
high until day 6, coincident with maximum accumulation
of donor cells. Virus clearance began after day 6 and titers
dropped to only several hundred PFU on day 8 (Fig. 1 C)
with no detectable virus after day 10 (unpublished data),
paralleling the decline in responding effector cells.
 
Kinetics of Division of CD4 T Cells.
 
The kinetics of cell
recovery suggested that the influenza-specific cells might be
responding first in the draining LN and spleen. To directly
analyze cell division in vivo, we combined analysis of ki-
netics of CFSE loss and BrdU incorporation. BrdU was
given orally to the infected hosts of CFSE-labeled naive
CD4 T cells, daily for two days intervals from 0 to 12 d af-
ter infection and cells recovered from these mice were ana-
lyzed for CFSE intensity and BrdU incorporation 1 d after
the final dose (Fig. 2 A). During the first 2 d after infection,
there was no change in the CFSE profile or BrdU incorpo-
ration among transferred cells from any site analyzed (Fig. 2
A, day 2). From day 2 to 4, 58% of donor cells recovered
from the MLN had divided as indicated both by BrdU in-
corporation and a shift in CFSE profile. A lower propor-
tion of less-divided cells were found in the spleen (25%).
Whether the dividing cells in the spleen came from the
MLN or were generated in the spleen is not clear, however
the higher total number of donor cells in the spleen (Fig. 1
A) and the fact that they had undergone fewer divisions, ar-
gues against the MLN as a primary source (Fig. 2 A). Many
donor cells in the spleen had not yet started to divide
(BrdU
 
negative
 
 and CFSE
 
high
 
). At day 4, there was no evi-
dence of cell division in nondraining LN and there were
no donor T cells recovered from lung or BAL. These re-
sults point to initial cell division in the draining LN fol-
lowed in a day or two by response in the spleen.
In the interval from day 4 to 6, high levels of BrdU in-
corporation continued indicating recent division among
donor cells in all sites and CFSE profiles indicated that the
majority of donor cells in both MLN and spleen had un-
dergone three or more rounds of division
 
,
 
 but there was a
persistent population of undivided cells in pLN spleen and
MLN. The progressive loss of CFSE from day 2 to 6 in
MLN and spleen and a relative loss of the undivided pop-
ulation with time suggested that naive cells were being re-
cruited into the response over several days, which is con-
sistent with a higher undivided, naive donor population
that is found in uninfected mice in spleen (2–5 
 
 
 
 10
 
5
 
) and
pLNs (1–2 
 
 
 
 10
 
4
 
). At day 6, donor cells first appeared in
the lung and BAL and only the most highly divided cells
were found in these sites. Division continued past day 6,
as indicated by the BrdU
 
 
 
 population recovered at day 8,
but had mostly ceased by day 10 (Fig. 2, A and B). It is
not possible to conclude from this analysis whether divi-
sion actively occurred in the lung and the BAL, or
whether all division occurred before the donor cell entry
(Fig. 2 B).
After day 15, BrdU incorporation among donor cells
returns to levels comparable to uninfected mice (unpub-
lished data).
Figure 2. Kinetics of division of donor CD4 T cells. Infected recipient
mice were generated as in Fig. 1. BrdU incorporation was analyzed at
48 h intervals, starting immediately after influenza infection up to day 12.
Each group of mice was fed orally for 2 d. On days 2, 4, 6, and 8 mice
were killed and tissue processed as described. (A) Kinetics of cell division,
dot plots of BrdU incorporation and CFSE profiles in the indicated or-
gans gated on CD4  Thy1.1  cells. The numbers in the top left quadrant
indicate the percentages of donor T cells that incorporated BrdU over a
48-h period. Data are representative of three mice per group and two in-
dependent experiments. (B) Percentages of BrdU  donor cells at the time
points indicated. 
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Phenotype of Responding Donor Cells in Secondary Lymphoid
Organs versus Lung.
 
To define the heterogeneity of the T
cells responding to influenza, we analyzed the cell surface
phenotype of the donor cells in different sites. By monitor-
ing the number of cell divisions together with the pheno-
typic changes that occur, we could correlate expression of
different molecules required for the recruitment of effector
cells into the inflammatory site with division. We focused
first on the expression of adhesion molecules and chemo-
kine receptors at the peak of the immune response (day 6;
Fig. 3). The cells in secondary lymphoid organs (both spleen
and MLN) were very heterogeneous for CFSE. There was a
rapid upregulation of the adhesion molecule CD44 which
interacts with epithelial hyaluronate (27, 28) after the first
division and levels of expression increased slightly as the cells
underwent further divisions. All the donor cells found in
lung and BAL expressed high levels of CD44 (Fig. 3 A).
Extravasation of naive T cells through high endothelial
venuoles into LNs is mediated in part by CD62L (29)
which interacts with peripheral-node addressin (PNAd)
present on Glycam-1, CD34, and podocalixin (30, 31).
CD4 effectors that had divided less than 5–6 times rarely
lost CD62L (Fig. 3 B), but after 8 divisions a large propor-
tion of the responding donor cells were CD62L
 
low
 
. Even
6 d after infection, a proportion (34 to 41%) of cells in the
spleen and LN that divided up to 8 times remained
CD62L
 
high
 
 (Fig. 3 B), revealing heterogeneity even among
the most divided donor cells (Table I). Strikingly, almost all
of the CD4 effector T cells that were found in the lung and
airways had down-regulated CD62L.
Firm adhesion of lymphocytes after initial selectin-medi-
ated tethering and rolling requires up-regulation of inte-
grins including members of the very late antigen subfamily,
such as CD49d (
 
 
 
4
 
 
 
1) and CD49e (
 
 
 
5
 
 
 
1) have been im-
plicated as the major players in firm adhesion by binding to
their ligands such as VCAM-1 and fibronectin (FN; refer-
ence 32). We found that between 60–70% of responding
donor cells expressed CD49d, and levels increased progres-
sively after 2 rounds of division. The majority of highly di-
vided cells in spleen, MLN, and lung expressed high levels
of CD49d (Table I). A high level of expression of CD49d
was seen in all donor cells that were recovered from the
lung and airways. CD49e was not up-regulated with divi-
sion or more highly expressed in the lung CD4 T cells
(unpublished data).
Chemokine receptor expression is also expected to play a
role in dictating T cell localization. Naive CD4 T cells ex-
press CCR7 which binds to ligands, SLC (CCL21) and
ELC/MIP-3
 
 
 
 (CCL19), which are expressed on high en-
dothelial venules favoring retention in the secondary tissues
(33–35). Loss of CCR7 has been suggested as a marker to
define the “effector memory” T cell subset, which is lo-
cated in nonlymphoid sites (10). We used the recombinant
CCR7 ligand, ELC-Ig chimeric molecule developed in
von Andrian’s laboratory, to detect CCR7 expression on
donor CD4 T cells (22). CCR7 was expressed on naive
donor T cells at high levels that were maintained for up to
7 cell divisions (Fig. 3 D). At day 6 and after 8 cell divisions
a small percentage of cells in secondary lymphoid tissues
had down-regulated CCR7: spleen (26%), pLN (12%), and
Figure 3. Phenotype of responding donor cells in
different sites infected recipient mice were generated as
in Fig. 1. After 6 d, cell suspensions from spleen, pLN,
MLN, lung, and BAL were prepared and donor cells
were identified by staining with anti-Thy1.1-Biotin
followed by streptavidin-APC and anti-CD4-Cy-
chrome. Expression of activation markers and CFSE
fluorescence of gated donor cells was analyzed. Markers
were: (A) CD44-PE, (B) CD62L-PE, (C) CD49d-PE,
(D) CCR7, detected using the ELC-Ig chimera fol-
lowed by anti–human-APC, (E) CCR5-PE, and (F)
CD25-PE. Quadrants were set relative to isotype con-
trols. The numbers in the top and bottom left quad-
rants indicate the percentages of cells expressing the in-
dicated marker. Three individual mice were analyzed
in each experiment, all were similar, one is shown.
Data are representative two different experiments. 
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MLN (23%). In contrast, the majority of donor T cells (70–
80%) that were recovered from the lung and BAL were
CCR7
 
negative
 
. CCR7 expression was still heterogeneous
among highly divided cells in LN (Table I). Thus, both
CD62L and CCR7 down-regulation were events which
occurred only on a fraction of the most highly divided do-
nor T cells and loss of both markers occurs late in the re-
sponse and is positively correlated with migration to the
lung (Fig. 3, and unpublished data).
CCR5 ligands: CCL3 (MIP-1
 
 
 
), CCL4 (MIP-1
 
 
 
), and
CCL5 (RANTES) are involved in transendothelial migra-
tion. All of these are induced in the lung early after influ-
enza infection (unpublished data). CCR5 has also been re-
ported to be preferentially expressed on Th1 effector cells
 
(36, 37). Of all the markers analyzed, CCR5 expression
was the most rare and it was highly expressed only on the
responding cells that had divided repeatedly. Between
8–14% of the donor T cells responding to influenza virus in
spleen and LNs expressed CCR5 at the peak of the im-
mune response (Fig. 3 E). A higher proportion of CD4 T
cells expressing CCR5 were found in the lung (22%). In-
terestingly, in the BAL, few cells expressed CCR5 (5%;
Fig. 3 E), despite the fact that the cells at this site were
highly activated by other criteria.
CD25, the IL-2R
 
 
 
, is up-regulated in response to opti-
mum T cell stimulation or high levels of IL-2. When effec-
tors are deprived of stimulation they quickly lose CD25 ex-
pression (26). At day 6 after influenza infection, we found
expression of CD25 on a fraction of responding donor cells
in MLN (13%), but it was expressed on few cells in spleen or
pLN (4 and 7%, respectively; Fig. 3 F). Interestingly, a larger
fraction of donor cells in lung and BAL expressed CD25 at
day 6 (23 and 34%, respectively; Fig. 3 F) and levels were
highest among the most divided cells in the lung and BAL
(Table I). The higher expression of CD25 on donor effec-
tors in the lung and BAL suggests that recruited cells are re-
encountering antigen and/or cytokines in the lung.
 
Phenotypic Heterogeneity After the Acute Phase of the Immune
Response. By day 15, donor cell numbers were low, cell
division had ceased and virus had been cleared. Phenotypic
analysis of the donor cells remaining at this time indicated
they were small cells (unpublished data) and that much of
the heterogeneity seen at day 6 still persisted (Fig. 4 A).
The CFSE profile remained much as it was at day 6 and
expression of CD44 and CD62L also showed a similar
Table I. Phenotype of Donor Cells Which Have
Undergone  6 Divisions
CD44
high
CD62L
low
CD49d
high
CCR7
low
CCR5
high
CD25
high
Spleen 100 73 97 74 15 4
pLN 100 42 69 56 13 16
MLN 100 83 86 59 4 17
Lung 100 95 90 85 13 26
BAL 100 95 83 86 7 37
The data from Fig. 3 was used to derive data on the cells which had
divided six or more times. We show the percentage of the divided cells
with each phenotype.
Figure 4. Phenotypic heterogeneity after
the acute phase of the immune response in-
fected recipient mice were prepared as in
Figs. 1–3 and harvested at various days up to
day 15. Donor cells, CFSE, and phenotypic
markers were identified as in Fig. 3. (A) Ex-
pression of CD44 and CD62L on gated do-
nor cells versus CFSE fluorescence on organs
harvested 15 d after influenza virus infection.
(B) Kinetics of expression of CCR5 and
CD25 at indicated days after influenza infec-
tion. Percentages of donor cells expressing
CCR5 and CD25 based on the total cell
number obtained per organ. Each point rep-
resents the mean of three mice per group.963 Román et al.
spectrum (Fig. 4 A). In contrast, CCR5 and CD25 were
down-regulated as the response waned (Fig. 4 B).
Further studies over 4 wk after infection indicated that
CFSE profiles remain heterogeneous and similar to those at
15 d, as do CD44 and CD62L profiles (unpublished data).
Cytokine Production by Responding Donor Cells. We also
analyzed cytokine production in spleen, pLN, MLN, lung,
and BAL at the peak of the response to influenza (day 6). In
all organs, the proportion of IFN- –producing cells in-
creased with greater numbers of cell division. At the peak
of response, day 6, the donor effector cells that had accu-
mulated at the inflammation site were able to produce par-
ticularly high amounts of IFN-  (lung 42%, BAL 46%).
Most striking was the observation that cells recovered from
the lungs and the BAL were able to produce IFN-  with-
out any restimulation in vitro (Fig. 5 A). The kinetics of
the ability to produce cytokine parallels the overall re-
sponse. By day 9 there was a dramatic decline in the num-
ber of cells that can produce both IFN-  and IL-2 (Fig. 5
B). This decrease correlated with clearance of virus from
the lung (Fig. 1 C). IL-2–producing cells increased in num-
ber at secondary sites with cell division, whereas cells re-
covered from lung and BAL produced less IL-2 than those
in the spleen and LN (Fig. 5 B).
Discussion
The results from this study support several major conclu-
sions. First, despite the fact that influenza virus is localized
exclusively to the lung, the primary response of the homo-
geneous population of naive antigen-specific TCR trans-
genic CD4 T cells is broadly systemic, occurring in drain-
ing MLNs, but also in the spleen, with less response only in
nondraining pLNs. Second, the response is vigorous with
extensive expansion of donor cells and it is extremely het-
erogeneous. The effector cells generated show a broad
spectrum of number of cell divisions they have undergone,
of several key phenotypic markers involved in migration
and function and of cytokine production. The picture seen
suggests multiple subsets which represent progressive stages
of differentiation and argue strongly against an “all-or-
none” model of response. Third, only a cohort of the ef-
fector cells, which have divided most and have acquired a
phenotype of high and stable CD44 and CD49d expres-
sion, transient expression of CCR5 and CD25, and low
expression of CD62L and CCR7, are subsequently re-
cruited into the lung and airways. The donor cells recov-
ered from the lung also produced the highest levels of IFN- 
and lowest levels of IL-2 and appear to represent the
most highly differentiated effector cells. Fourth, the distinc-
tive heterogeneous profile of donor cells in the secondary
sites versus the lungs was maintained at least to day 15, 5 d
after viral clearance, indicating effectors can become “fro-
zen” along a differentiation pathway once stimulation is re-
moved and suggesting that memory heterogeneity may be
a direct reflection of effector heterogeneity. These results
suggest that the effector response is by nature heteroge-
neous and that because extravasation into tertiary sites re-
quires a unique pattern of selectins, adhesion molecules,
and chemokine receptors, the cells reaching the lung and
forming memory in that site are a unique cohort of the to-
tal spectrum in secondary sites. We suggest that these phe-
Figure 5. Cytokine production by responding donor
cells. Infected recipient mice were prepared as in Fig. 3. At
day 6, donor cells in spleen, a pool of nondraining (pLN),
MLN, lung, and BAL were analyzed for their capacity to
produce cytokines in vitro after restimulation with and
without PMA and Ionomycin for 4 h in the presence of
BFA for the last 2 h. (A) IFN- –producing cells gated on
donor cells. (B) IL-2–producing cells gated on donor cells.
(C) Kinetic analysis of absolute numbers of donor cells ex-
pressing the indicated cytokine at different days after influ-
enza infection.964 CD4 Effectors Generated in Response to Influenza Are Heterogeneous
nomenon are likely to be responsible for the development
of memory subsets which have been previously labeled
“central” and “effector” memory (13).
Division and Expansion in Different Sites. A key feature
of the response to influenza is a rapid and extensive division
of the stimulated naive CD4 T cells, which results in a very
large effector population, but which nonetheless results in a
series of effector subsets which differ in the number of divi-
sions they have experienced. The first divisions of the do-
nor Tg CD4 T cells occurred in the draining LN, followed
closely by division in the spleen, then nondraining nodes
(Fig. 2 A). The peak of specific CD4 T cell division paral-
leled the accumulation of large donor effector cell popula-
tions in the spleen and only at this time did donor cells be-
come detectable in lung and BAL. When donor cells
appeared in the lung/airway they had recently divided and
they represented the cells that had undergone the most di-
visions (Fig. 2 A). The largest absolute numbers of donor
cells were found in the spleen (over 4 million), but the
highest representation of donor CD4 T cells was in the
lung and BAL (Fig. 1 B). These observations are most
compatible with the concept that the high numbers of ef-
fectors were generated in the multiple secondary sites and
subsequently the cohort of most divided and differentiated
effector cells migrated into the lung. This correlation does
not necessarily imply that large numbers of divisions are re-
quired for cells to be recruited into the inflammatory site
(5). Instead we suggest that the cells that have undergone
multiple rounds of division are also most likely to be the
cells expressing other characteristics enabling them to be
recruited (see below). Our results in fact support the con-
cept that T cell division is not strictly linked to recruit-
ment, as many effector cells found in the secondary sites by
day 4 had divided at least eight times, but none were re-
cruited into the lung until later and only the cells which
had lost CD62L regardless of division were found in the
lung even late in the response (Fig. 4 A).
The systemic nature of the response to influenza con-
trasts with that recently reported to Salmonella (38) in that
CD4 T cells responded in spleen and many LNs even
though virus is confined to the lung, while in the Salmo-
nella study, infection was disseminated, but the response
was confined to the intestinal mucosa. It is not clear if the
distribution of the responding cells vary because the organ-
isms trigger different types of inflammatory response or be-
cause the TCR affinities for the antigens are different.
Another dramatic feature of the influenza-induced re-
sponse is that it rapidly declines after the peak at day 6. Af-
ter day 8, new division is less frequent, which correlates
with the abrupt drop in viral titer between day 6 and 8 (no
virus is detectable by day 10). After viral clearance the initi-
ation of responses of new naive cells ceases. This is consis-
tent with the concept that dendritic cells survive and
present antigen in peripheral sites only for a short time (39,
40). At the same time as division slows and then stops,
there is a marked and coordinated decline in donor cell
numbers in all organs tested. It is unlikely this decline is
due to relocation because it occurs concurrently in all sites
and it is thus likely due to the programmed cell death of
donor effector cells. Activation-induced cell death may be
important in the lung where the activation state and consti-
tutive cytokine production, suggest ongoing presentation
of antigen, but the dramatic decline in peripheral sites is
likely to occur without the need for antigen, suggesting it is
part of the intrinsic death program of effectors as has been
suggested for in vitro–generated Th1 effectors (41).
Adhesion, Homing, and Chemokine Receptors Profiles in Dif-
ferent Sites. There are both strong and weak correlations
between cell surface phenotype and the location of the ef-
fector populations, which suggest that some of these may
be directly involved in migration of effectors to the lung.
Overall, more CD4 effector cells in the lung expressed
higher levels of CD44, CD49d, and CCR5 and lower lev-
els CD62L and CCR7 than the total population in spleen
and MLN in keeping with a number of earlier studies of
migration to inflammatory sites (27, 28, 31, 32). The cells
recruited into the lung were all CD44 high, but since
CD44 was up-regulated early on all the cells that divided
and many CD44 high cells were not recruited to the lung,
high CD44 expression could be necessary but not sufficient
for lung recruitment. The integrin CD49d, showed in-
creasing expression with time (unpublished data) and cell
division but there was a wide spectrum of CD49d expres-
sion levels among the highly divided population. Donor
CD4 cells found at the site of inflammation were mostly
CD49d high, so this integrin could potentially be involved
in recruitment. In secondary lymphoid sites, loss of CD62L
was only seen late and on highly divided donor cells and
even on the most divided cells, up to 40% still expressed
CD62L. The heterogeneity in the expression of CD62L in
donor cells recovered from secondary lymphoid tissue,
even in the most highly divided population, suggests that
signals beyond those needed for division are required for
CD62L down-regulation. Donor cells recovered from the
lung and BAL, were uniformly CD62L low and thus
down-regulation of CD62L selectin may be necessary for T
cells to escape lymphoid sites and be recruited into non-
lymphoid sites. After response has ended, the donor cells
found in spleen and other secondary lymphoid organs re-
main heterogeneous in expression of CD62L (Fig. 4 A),
while those in the lung all remain low.
The chemokine receptor, CCR7 displays a similar pat-
tern to CD62L in the secondary lymphoid organs, though a
smaller fraction of the highly divided cells have lost CCR7.
In the lung, the majority of donor cells detected were
CCR7 negative, but some cells expressed low levels of
CCR7. This imperfect correlation suggests that CCR7 loss
is not absolutely required for recruitment into the lung, al-
though its loss may be associated with other changes which
favor this recruitment. It is notable that the expression of
CCR7 in the secondary site versus the lung mirrors that
described earlier for memory cells in secondary Vs tissue
sites (11). It will be interesting to determine whether par-
ticular chemokine receptor expression patterns represent
heritable traits or whether they are under constant regula-
tion by local signals.965 Román et al.
CCR5 is up-regulated on a small fraction of the most
divided donor cells responding in spleen and LN and the
population found in the lung is enriched in cells expressing
CCR5. It is possible that cells that enter the lung are in-
variably higher in CCR5 expression, but that the receptor
is then down-regulated as it encounters its ligands induced
in the lung by viral infection (42). Indeed the cells in the
BAL, which transit through the lung, do not express
CCR5. Alternatively, CCR5 may be only one of several
chemokine receptors involved in lung entry as suggested
by the fact that humans and mice with deficiencies of the
CCR5 molecule do not have markedly defective immune
responses (43). With time after the peak of response,
CCR5 expression decreases, suggesting that CCR5 ex-
pression may be associated with an activated state (Fig. 4
B). Earlier studies using human cells derived from differ-
ent inflammatory conditions analyzed the expression of
CCR7, CD27, CD62L, together with CD27 and CD11b,
and also found a series of heterogeneous overlapping pop-
ulations (44). Further studies will be needed to determine
which chemokine receptors play active roles in recruit-
ment to the lung.
During the differentiation of CD4 effectors in vivo,
CD25 expression is weak and transient (unpublished data).
CD25 (the IL-2R ) expression can be upregulated by ex-
posure to antigen and to IL-2 itself (45, 46), but ambient in
vivo levels of IL-2 may be low or negligible. Thus, it was
striking that there was a clear population of CD25-express-
ing cells detectable at the peak of the response on donor
cells in lung and BAL (Fig. 3 F). This population was as
high as 75% on day 5 (Fig. 4 B) and then declined, whereas
little expression was seen in secondary sites (Fig. 3 F). We
suggest this high expression of CD25 is due to recent expo-
sure of the responding cells in lung and BAL to antigen.
This is also suggested by the production of cytokine ex
vivo without restimulation by these same populations (see
below) and with the fact that expression is lost by day 10
when antigen is no longer present (Fig. 4 B).
Overall the phenotypic patterns suggest that only after
repeated division and maximum differentiation do effectors
express the pattern of integrins, selectins, and chemokine
receptors which enable their recruitment to the lung, and
by inference other tertiary, nonlymphoid sites. It is impor-
tant to focus on how to achieve this maximum differentia-
tion, as the cell which can go to the site of infection are the
ones that can participate in viral clearance. Also of interest
is that even in this vigorous response, a broad spectrum of
effectors which range over the gamut of properties are re-
tained in spleen and LN and a fraction of each is retained
after viral clearance. This multipotential population may
have some advantage in a secondary response.
Cytokine Polarization and Production in Different Sites.
The link between division and cytokine expression by T
cells remains controversial. Cytokine expression by T cells
involves epigenetic changes in chromatin structure, locus
accessibility, and DNA methylation that occur during T
cell differentiation (47). Production of high levels of IFN- 
and IL-4 production require S phase entry and are often
well-correlated in vitro with multiple rounds of cell divi-
sion (48–50). However, others have reported that T cell di-
vision is not strictly linked to effector function. When CD4
T cells cannot divide in vivo because antigen-specific T
cells are overrepresented, they nonetheless can acquire the
capacity to produce IFN-  (5) and similar results were ob-
served in an in vitro model examining IL-4 production
(51). In our studies, we have found that cell division corre-
lated well with the capacity to produce IFN- , although
this does not imply a causal link. More effector cells found
in the lung produced IFN-  compared with those from the
secondary lymphoid tissues. Previous observations from
Jenkins (9) suggested that memory cells isolated from non-
lymphoid tissues were more efficient producers of IFN- .
The antiviral responses we examined clearly favored devel-
opment of a Th1-polarized response. No IL-4 or IL-5 pro-
duction was found by ex vivo intracellular cytokine stain-
ing (ICCS; unpublished data), and as with the most
differentiated effectors in vitro (52), IL-2 was relatively
down-regulated on the cells recruited to the lung.
Heterogeneity of Effector Response. What accounts for the
striking heterogeneity seen in the effectors derived from
the homogeneous naive CD4 TCR Tg T cells? One fac-
tor could be time. Division and progressive loss of the
CFSE high undivided population of cells continued in the
spleen through day 8 (Fig. 2 A), suggesting that naive cells
continue to be recruited into the response. Perhaps with
more time there is an increase in the probability that an
individual naive cell will encounter an appropriate APC.
Such changes ceased abruptly after day 8 in parallel with
viral clearance, supporting a short half-life of antigen-pre-
senting capacity and the obligatory role of continuing an-
tigen stimulation in driving the overall response. It ap-
pears as if differentiation stops as antigen presenting cells
die and that responding cells can become fixed in an in-
completely differentiated state. The fact that a diverse
spectrum of cells is retained through day 15 (Fig. 4) sup-
ports this model.
Although the starting enriched naive population is
 95% Tg , there are sometimes small population of
CD62L donor cells (up to 10%) and it could be argued that
this heterogeneity in the starting population contributes to
the heterogeneity observed. This seems unlikely. We have
FACS®-sorted CD62L high (the major naive population)
and CD62L low (the minor contaminating population) and
both give rise to heterogeneous effectors, with a spectrum
indistinguishable from the unsorted population shown in
these experiments (unpublished data).
Diversity within the APC populations could also result
in heterogeneity. APCs might differ either in expression of
costimulatory receptors or in the density of viral hemagglu-
tinin they present. This might lead to a partial response by
naive cells encountering the suboptimal APCs. The cyto-
kines produced by individual APCs or in particular milieus
could also be distinct. The concept that different cytokines
will lead to different effector and memory populations has
recently been put forth by von Andrian’s laboratory (17).
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antigen density on APC may influence heterogeneity of
naive CD4 T cell response.
The heterogeneity of response argues against the “all-or-
none” response model suggested by Ahmed (4) studying
LCMV and others (2, 3) and instead indicates that, at least
for CD4 T cells, the responding cells need multiple signals
for full differentiation and that they will become arrested in
division and differentiation when they do not encounter
the later signals in the chain. This kind of progression is
easily detected in vitro where it has been shown that anti-
gen and costimulation together drive initial activation and
division of responding naive CD4 T cells, but that IL-2, or
perhaps other signals, are required for further division and
differentiation to fully polarized effectors (52, 53). The dif-
ference in our study and the CD8 studies with LCMV,
could be due to the nature of the pathogen used. Influenza
clearance is effective and abrupt, curtailing further re-
sponse. The heterogeneity of the effector response may be
a useful adaptation in that the less differentiated cells may
retain the plasticity to respond in different ways to reen-
counter with antigen. Whether the different populations
found have different potential in secondary responses needs
to be further explored. It will also be important in future
studies to define what markers and functions represent sta-
ble, heritable traits and which are transiently regulated re-
gardless of state of differentiation.
Effector cells generated during a primary immune re-
sponse can either remain in the lymphoid tissue or migrate
to peripheral tissues including inflammatory sites and other
nonlymphoid sites distributed widely throughout the body
(8, 9). Recently it has been suggested that cells in the lung
can persist to some degree and function as protective
memory cells in a recall response (6). Moreover, Lanzavec-
chia and colleagues have proposed that memory cells can
be usefully divided into two major subpopulations that can
be distinguished by the differential expression of CD62L
and the chemokine receptor CCR7 (10). The “central
memory” cells express CCR7 and CD62L and are found
in spleen and other secondary lymphoid organs and “effec-
tor memory” cells which are CCR7 and CD62L negative
are found in peripheral tissues (10). Our studies suggest
that the primary response generates a broad spectrum of ef-
fector cell subsets, varying in a large number of function-
ally significant phenotypic markers and abilities to migrate
into inflammatory sites and that those cells able to enter the
lung represent those cohorts of the effector cells which
have divided the most, have lost CD62L and CCR7, ex-
press high levels of activation markers and integrins, and
have high expression of the effector cytokine IFN-  and
loss of IL-2. Although this pattern corresponds roughly
with Lanzavecchia’s depiction of “effector memory,” the
picture here is somewhat more complex. All types of effec-
tors, including cells that resemble the cohort in the lung,
seem to be found in secondary sites, especially the spleen,
and much heterogeneity is retained at for at least 15 d, days
past the time virus is cleared and donor cells have reverted
to a nondividing small cells. We predict this heterogeneity
will be maintained longer and that memory in secondary
sites will likewise includes a large spectrum of subsets. It
should be noted that even in the lung, there is considerable
heterogeneity in CD62L, in CCR5, and in CCR7 expres-
sion. This suggests that effectors go through progressive
stages of differentiation and acquire properties which dic-
tate their subsequent location, leading to distinct central Vs
peripheral populations. This argues against a simple dichot-
omy of central versus peripheral effector and memory cells
which are the result of two lineages, and instead imply that
the cohort in the periphery represent the most differenti-
ated subsets of the broader spectrum of subsets in second-
ary lymphoid sites.
These studies reveal a here-to-fore unappreciated com-
plexity of the primary antiviral response which results in a
spectrum of effectors with a phenotypic diversity suggest-
ing a broad range of functional potentials.
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